Scope
Human germline/embryo gene editing and novel biomedical technologies can trigger heightened ethical, biosafety, HGR and criminal-law scrutiny; institutional IRB approval alone may be insufficient.
Search the portal
China legal tool China law National framework
Interactive China legal orientation tool. Review the result with the relevant legal guide and qualified counsel where facts or local implementation matter.
Human germline/embryo gene editing and novel biomedical technologies can trigger heightened ethical, biosafety, HGR and criminal-law scrutiny; institutional IRB approval alone may be insufficient.
Use the output to organize the facts, then confirm the source, evidence, local implementation and available remedy before acting.